These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

899 related items for PubMed ID: 17996926

  • 1. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R, Japanese Gynecologic Oncology Group.
    Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y, Watanabe M, Amikura T, Obata H, Sekine M, Yahata T, Fujita K, Tanaka K.
    Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
    [Abstract] [Full Text] [Related]

  • 3. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA.
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [Abstract] [Full Text] [Related]

  • 4. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar 01; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
    Hidaka T, Nakamura T, Shima T, Yuki H, Saito S.
    J Obstet Gynaecol Res; 2006 Jun 01; 32(3):330-7. PubMed ID: 16764625
    [Abstract] [Full Text] [Related]

  • 8. [Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer].
    Wen HW, Tian F, Ma L, Liao QP.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Mar 01; 44(3):196-9. PubMed ID: 19570445
    [Abstract] [Full Text] [Related]

  • 9. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG, Gynecologic Oncology Group.
    Gynecol Oncol; 2004 Mar 01; 92(3):744-51. PubMed ID: 14984936
    [Abstract] [Full Text] [Related]

  • 10. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.
    Gynecol Oncol; 2009 Sep 01; 114(3):442-7. PubMed ID: 19560193
    [Abstract] [Full Text] [Related]

  • 11. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct 01; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
    Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA, Gynecologic Oncology Group Study.
    J Clin Oncol; 2006 Jan 01; 24(1):36-44. PubMed ID: 16330675
    [Abstract] [Full Text] [Related]

  • 13. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
    McMeekin DS, Filiaci VL, Thigpen JT, Gallion HH, Fleming GF, Rodgers WH, Gynecologic Oncology Group study.
    Gynecol Oncol; 2007 Jul 01; 106(1):16-22. PubMed ID: 17574073
    [Abstract] [Full Text] [Related]

  • 14. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
    Yahata H, Hirakawa T, Fujita T, Ariyoshi K, Sonoda K, Amada S, Kobayashi H, Nakano H.
    Int J Clin Oncol; 2004 Aug 01; 9(4):317-21. PubMed ID: 15375709
    [Abstract] [Full Text] [Related]

  • 15. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
    Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S.
    J Clin Oncol; 2004 Oct 01; 22(19):3902-8. PubMed ID: 15459211
    [Abstract] [Full Text] [Related]

  • 16. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T.
    Gynecol Oncol; 2006 Oct 01; 103(1):155-9. PubMed ID: 16545437
    [Abstract] [Full Text] [Related]

  • 17. Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.
    Fowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS.
    Gynecol Oncol; 2009 Mar 01; 112(3):553-7. PubMed ID: 19135232
    [Abstract] [Full Text] [Related]

  • 18. Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy.
    Aoki Y, Kase H, Watanabe M, Sato T, Kurata H, Tanaka K.
    Gynecol Oncol; 2001 Oct 01; 83(1):1-5. PubMed ID: 11585406
    [Abstract] [Full Text] [Related]

  • 19. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM, Venkatraman E, Chi DS, Barakat RR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):111-7. PubMed ID: 15850910
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.
    Kim HS, Kim JW, Wu HG, Chung HH, Park NH, Song YS, Kang SB, Lee HP.
    J Obstet Gynaecol Res; 2010 Jun 01; 36(3):598-604. PubMed ID: 20598043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.